Arsenic in drinking-water and risk for cancer in Denmark

Environmental Health Perspectives

Volumn 116, Issue 2, 2008, Pages 231-237

  Baastrup, Rikke ^a   Sørensen, Mette ^a   Balstrøm, Thomas ^b   Frederiksen, Kirsten ^a   Larsen, Carsten Langtofte ^c   Tjønneland, Anne ^a   Overvad, Kim ^d   Raaschou Nielsen, Ole ^a  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c GEOLOGICAL SURVEY OF DENMARK AND GREENLAND   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Arsenic; Cancer; Cohort study; Drinking water; Geographic information system

Indexed keywords

ARSENIC; DRINKING WATER;

ADULT; ARTICLE; BLADDER CANCER; CANCER REGISTRY; CANCER RISK; CARCINOGENICITY; COHORT ANALYSIS; COLORECTAL CANCER; CONCENTRATION RESPONSE; DENMARK; ENVIRONMENTAL EXPOSURE; FEMALE; GEOGRAPHIC INFORMATION SYSTEM; HUMAN; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; SKIN CANCER; WATER SUPPLY;

ARSENIC; CARCINOGENS; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; WATER SUPPLY;

EID: 40549094299     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.10623     Document Type: Article

References (39)

1. Abernathy CO, Chappell WR, Meek ME, Gibb H, Guo HR. 1996. Is ingested inorganic arsenic a "threshold" carcinogen? Fundam Appl Toxicol 29:168-175.
2. Abernathy CO, Thomas DJ, Calderon RL. 2003. Health effects and risk assessment of arsenic. J Nutr 133:1536S-1538S.
3. Agency for Toxic Substances and Disease Registry. 2005. Toxicological Profile for Arsenic (Draft for Public Comment). GA:U.S. Department of Health and Human Services.
4. Bates MN, Rey OA, Biggs ML, Hopenhayn C, Moore LE, Kalman D, et al. 2004. Case-control study of bladder cancer and exposure to arsenic in Argentina. Am J Epidemiol 159:381-389.
5. Bates MN, Smith AH, Cantor KP. 1995. Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol 141:523-530.
6. Burns FJ, Uddin AN, Wu F, Nadas A, Rossman TG. 2004. Arsenic-induced enhancement of ultraviolet radiation carcinogenesis in mouse skin: a dose-response study. Environ Health Perspect 112:599-603
7. Chan CJ, Chuang YC, You SL, Lin TM, Wu HY. 1986. A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer 53:399-405.
8. Chen CJ, Kuo TL, Wu MM. 1988. Arsenic and cancers. Lancet 1:414-415.
9. Cohen SM, Ohnishi T, Arnold LL, Le XC. 2007. Arsenic-induced bladder cancer in an animal model. Toxicol Appl Pharmacol 222:258-263.
10. Farago ME, Thornton I, Kavanagh P, Elliott P, Leonardi GS. 1997. Health aspects of human exposure to high arsenic concentrations in soil in south-west England. In: Arsenic: Exposure and Health Effects (Abernathy CO, Calderon RL, Chappell WR, eds). London:Chapman & Hall, 210-226.
11. Ferreccio C, Gonzalez C, Milosavjlevic V, Marshall G, Sancha AM, Smith AH. 2000. Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology 11:673-679.
12. Greenland S. 1995. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 6:356-365.
13. Hopenhayn-Rich C, Biggs ML, Fuchs A, Bergoglio R, Tello EE, Nirolli H, et al. 1996. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemioloy 7:117-124.
14. Hopenhayn-Rich C, Biggs ML, Smith AH. 1998. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int J Epidemiol 27:561-569.
15. Jones AQ, Dewey CE, Dore K, Majowicz SE, McEwen SA, Waltner-Toews D. 2006. Exposure assessment in investigations of waterborne illness: a quantitative estimate of measurement error. Epidemiol Perspect Innov doi: 10.1186/1742-5573-3-6 [Online 26 May 2006].
16. Karagas MR, Stukel TA, Morris JS, Tosteson TD, Weiss JE, Spencer SK, et al. 2001. Skin cancer risk in relation to toe-nail arsenic concentrations in a US population-hased case-control study. Am J Epidemiol 153:559-565.
17. Karagas MR, Stukel TA, Tosteson TD. 2002. Assessment of cancer risk and environmental levels of arsenic in New Hampshire. Int J Hyg Environ Health 205:85-94.
18. Knobeloch LM, Zierold KM, Anderson HA. 2006. Association of arsenic-contaminated drinking-water with prevalence of skin cancer in Wisconsin's Fox River Valley. J Health Popul Nutr 24:206-213.
19. Kurttio P, Pukkala E, Kahelin H, Auvinen A, Pekkanen J. 1999. Arsenic concentrations in wcll water and risk of bladder and kidney cancer in Finland. Environ Health Perspect 107:705-710.
20. Lamm SH, Engel A, Kruse MB, Feinleib M, Byrd DM, Lai S, et al. 2004. Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 U.S. counties and 30 years of observation. J Occup Environ Med 46:298-306.
21. Lewis DR, Southwick JW, Ouellet Hellstrom R, Rench J, Calderon RL. 1999. Drinking water arsenic in Utah: a cohort mortality study. Environ Health Perspect 107:359-365.
22. Marshall G, Forreccio C, Yuan Y, Bates MN, Steinmaus C, Selvin S, et al. 2007. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J Natl Cancer Inst 99:920-928.
23. Mohri T, Hisanaga A, Ishinishi N. 1990. Arsenic intake and excretion by Japanese adults: a 7-day duplicate diet study. Food Chem Toxicol 28:521-529.
24. Rossman TG, Uddin AN, Burns FJ. 2004. Evidence that arsenite acts as a cocarcinogen in skin cancer. Toxicol Appl Pharmacol 198:394-404.
25. Rothman K. 2002. Biases in study design. In: Epidemiology: An Introduction. New York:Oxford University Press, 94-112.
26. Schoen A, Beck B, Sharma R, Dube E. 2004. Arsenic toxicity at low doses: epidemiological and mode of action considerations. Toxicol Appl Pharmacol 198:253-267.
27. Scotto J, Fears TR, Fraumeni J. 1996. Solar radiation. In: Cancer Epidemiology and Prevention (Schottenfield D, Fraumeni J, eds), New York:Oxford University Press, 355-372.
28. Smedley P, Kinniburgh DG. 2005. Arsenic in groundwater and the environment. In: Essentials of Medical Geology: Impacts of the Natural Environment on Public Health (Selinus O, Alloway BJ, Centeno JA, Finkelman RB, Fuge R, Lindh U, et al., eds). Amsterdam:Elsevier Academic Press, 263-295.
29. Snow ET, Sykora P, Durham TR, Klein CB. 2005. Arsenic, mode of action at biologically plausible low doses: What are the implications for low dose cancer risk? Toxicol Appl Pharmacol 207:557-564.
30. Steinmaus C, Yuan Y, Bates MN, Smith AH. 2003. Case-control study of bladder cancer and drinking water arsenic in the western United States. Am J Epidemiol 158:1193-1201.
31. Storm HH, Michelson EV, Clemmensen IH, Pihl J. 1997. The Danish Cancer Registry - history, content, quality and use. Dan Med Bull 44:535-539.
32. Tchounwou PB, Centeno JA, Patlclla AK. 2004. Arsenic toxicity, mutagenesis, and carcinogenesis - a health risk assessment and management approach. Mol Cell Biochem 255:47-55.
33. Thomson R, Søndergaard VH, Sørensen KI, 2004. Hydrogeological mapping as a basis for establishing site-specific groundwater protection zones in Denmark. Hydrogeol J 12:550-562.
34. Tjønneland A, Olsen A, Boll K, Stripp C, Christensen J, Engholm G, et al. 2007. Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health doi:10 1080/14034940691047986 [Online 12 January 2007].
35. Tsuda T, Babazono A, Yamamoto E, Kurumatani N, Mino Y, Ogawa T, et al. 1995. Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. Am J Epidemiol 141:198-209.
36. Vahter, M, Li, L, Nermell, B, Rahman, A, El Arifeen, S, Rahman, M, et al. 2006. Arsenic a global public health problem [Abstract]. Toxicol Lett 164S:s45-s46.
37. Waalkes MP, Liu J, Diwan BA. 2007. Transplacental arsenic carcinogenesis in mice. Toxicol Appl Pharmacol 222:271-280.
38. Wanibuchi H, Salim El, Kinoshita A, Shen J, Wei M, Mórimura K, et al. 2004. Understanding arsenic carcinogenicity by the use of animal models. Toxicol Appl Pharmacol 198:366-376.
39. Wu MM, Kuo TL, Hwang YH, Chen CJ. 1989. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 130:1123-1132.